Ep30: Orilissa and Lupron. Part 1 – Big Pharma’s Influence on Endo Information

Episode updated 11/2022. Why are doctors so misinformed about treatment for endometriosis, and the benefits, risks, and limitations of GnRh drugs like Orilissa and Lupron? We talk about how drug companies are influencing both the doctor and the patient through marketing tactics, “awareness” campaigns, underwriting medical education credits for doctors, and more. We also talk about the lack of transparency around these tactics, how this misinformation affects our standard of care, and the quick facts around Orilissa and Lupron.

CONNECT WITH US! INSTAGRAM: @in16yearsofendo

WEBSITE AND RESOURCES: insixteenyears.com

LIKE OUR SHOW? Please rate it or leave a review!

SUPPORT US by buying us a coffee: https://ko-fi.com/insixteenyears


–Lupron: insixteenyears.com/lupron

–Orilissa: insixteenyears.com/orilissa

Leave a Reply

Your email address will not be published. Required fields are marked *